InvestorsHub Logo
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Re: None

Tuesday, 03/17/2015 12:23:12 PM

Tuesday, March 17, 2015 12:23:12 PM

Post# of 23979
AOLS Aeolus Receives Orphan Drug Designation From US FDA for AEOL 10150 for Treatment of Idiopathic Pulmonary Fibrosis

"Orphan Drug Designation entitles the sponsor to a seven-year marketing exclusivity period, clinical protocol assistance with the FDA, as well as federal grants and tax credits."


Keep this one on your list. They have a phase one cancer trial coming up for the effects of radiation on the lungs. Lots of good stuff ahead here.

http://finance.yahoo.com/news/aeolus-receives-orphan-drug-designation-154629158.html

Email: sheepery@gmail.com

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.